(+035) 527-1710-70
EastGate Biotech Enters into a Financial Agreement
EastGate Biotech Enters into a Financial Agreement
Terms of the Agreement reflects long term vision and supports company’s busin...
09
Mar
Posts by admin
09
Mar
EastGate Biotech Announces Joint Venture with Netris/Origin Biopharmaceuticals for Pakistani Market
Drug Development and Nutraceuticals Covered in JV.
WEST CALDWELL, NJ and TORONTO, April 17, 2018 (AccessNewswire-) Eas...
09
Mar
EastGate Biotech Announces Definitive Agreement with Genluiching Mining Corporation.
EastGate to receive funding in tranches up to $5 million USD.
WEST CALDWELL, NJ and TORONTO, April 10, 2018 (AccessNewswire-) ...
09
Mar
EastGate Biotech Corp., CEO Anna Gluskin and President, Rose Perri Visit Uptick Newswire’s “Stock Day” with Everett Jolly
https://finance.yahoo.com/news/eastgate-biotech-corp-ceo-anna-120000005.html
09
Mar
EastGate Biotech Announces that it has reached a Definitive Settlement Agreement with Northbridge Financial Inc..
The Share Reserve with Transfer Agent has been cancelled and all remaining shares have been returned to EastGate Biotech.
WEST C...
09
Mar
EASTGATE BIOTECH ENTERS INTO A MOU WITH GENLUICHING MINING CORP. & AAH & INTERNATIONAL ASSOCIATES INC. OF THE PHILIPPINES
WEST CALDWELL, NJ and TORONTO, March 13, 2018 (AccessNewswire-) EastGate Biotech Corp. (PinkSheets: ETBI), a pharmaceutical company...
09
Mar
EASTGATE BIOTECH ANNOUNCES LICENSING/DISTRIBUTION MOU WITH BUPHARCO FOR THE INSULIN MOUTH RINSE IN THE PHILIPPINES FOR TYPE 2 DIABETES PATIENTS
WEST CALDWELL, NJ and TORONTO, March 5, 2018 (AccessNewswire-) EastGate Biotech Corp. (PinkSheets: ETBI), a pharmaceutical company that...
09
Mar
EASTGATE BIOTECH ANNOUNCES LICENSING/DISTRIBUTION MOU WITH BUPHARCO FOR THE INSULIN MOUTH RINSE IN THE PHILIPPINES FOR TYPE 2 DIABETES PATIENTS
WEST CALDWELL, NJ and TORONTO, March 5, 2018 (AccessNewswire-) EastGate Biotech Corp. (PinkSheets: ETBI), a pharmaceutical company ...
09
Mar
EASTGATE BIOTECH PROVIDES CORPORATE UPDATE
WEST CALDWELL, NJ and TORONTO, February 27, 2018 (AccessNewswire/-) EastGate Biotech Corp. (PinkSheets: ETBI), an emerging pharmaceutic...
09
Mar
EastGate Biotech Announces Annual Report Form 10-K Filing
Toronto, ON, February 28th, 2018 – EastGate Biotech (OTC BB: ETBI) a market leading pharmaceutical technology company, today announce...